On the other hand, a prospective, clinic-based study, which evaluated visual outcomes after 6 months of anti-VEGF treatment, demonstrated that longer treatment delay from first symptoms of CNV was, in multivariate analysis, a highly significant predictor of adverse visual outcome, by limiting the ability to gain vision with treatment [ 10 ].
← all excerpts
Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes.
1
—
—